Cargando…
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
Since the emergence of the original SARS-CoV-2, several variants were described, raising questions as to the ability of recently developed vaccine platforms to induce immunity and provide protection against these variants. Here, we utilized the K18-hACE2 mouse model to show that VSV-ΔG-spike vaccina...
Autores principales: | Yahalom-Ronen, Yfat, Tamir, Hadas, Melamed, Sharon, Politi, Boaz, Achdout, Hagit, Erez, Noam, Israeli, Ofir, Cohen-Gihon, Inbar, Chery Mimran, Lilach, Barlev-Gross, Moria, Mandelboim, Michal, Orr, Irit, Feldmesser, Ester, Weiss, Shay, Beth-Din, Adi, Paran, Nir, Israely, Tomer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303402/ https://www.ncbi.nlm.nih.gov/pubmed/37376662 http://dx.doi.org/10.3390/v15061364 |
Ejemplares similares
-
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2022) -
A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020) -
Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022) -
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus
por: Vitner, Einat B., et al.
Publicado: (2021) -
Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains
por: Israely, Tomer, et al.
Publicado: (2019)